Search research articles
Contact Us
Filters
Showing results (71-80 of 80) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 80 results.
Cancer Immunology, Immunotherapy : CII
|
April 15, 2023
Characteristic differences in the abundance of tumor-infiltrating lymphocytes and intratumoral developing T cells in thymoma, with special reference to PD-1 expression
Tatsuo Furuya, Shunta Ishihara, Hiroshi Ogi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
October 27, 2024
[Safety and Efficacy of Nivolumab plus Ipilimumab Therapy-Our Real World Experience]
Ryuichi Morita, Takeshi Ishikawa, Toshifumi Doi, et al.
Molecular Biology of the Cell
|
November 19, 2025
Hydrostatic pressure from basal side promotes cancer proliferation, enhances migration, and alters cell polarity: A model of the effects of interstitial fluid pressure in tumor microenvironment
Keisuke Onoi, Aosa Nakamura-Sasada, Shinsaku Tokuda, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 1, 2019
Comparing three different anti-PD-L1 antibodies for immunohistochemical evaluation of small cell lung cancer
Akihiro Yoshimura, Tadaaki Yamada, Aya Miyagawa-Hayashino, et al.
Cancers
|
October 14, 2022
Phosphoproteomic Analysis Identifies TYRO3 as a Mediator of Sunitinib Resistance in Metastatic Thymomas
Stefan Küffer, Jessica Grabowski, Satoru Okada, et al.
Translational Lung Cancer Research
|
July 17, 2025
Impact of mutant protein expression on clinical outcomes in patients with EGFR L858R-mutated non-small cell lung cancer
Ryota Nakamura, Tadaaki Yamada, Kenji Morimoto, et al.
Annals of Surgical Oncology
|
February 26, 2026
Efficacy and Safety of Salvage Surgery After Immunotherapy in Non-small Cell Lung Cancer: A Multi-institutional Retrospective Study
Shinya Tane, Megumi Nishikubo, Takehiko Manabe, et al.
Cell Death & Disease
|
December 3, 2025
Proteasome inhibition as a potential therapeutic target in thymic cancer
Satoru Okada, Louisa Benter, Leon Schrell, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 1, 2026
Lack of impact of antibiotics and proton pump inhibitors on the efficacy of preoperative chemoimmunotherapy in locally advanced non-small cell lung cancer: A multicenter retrospective study
Michihito Toda, Kazuki Takada, Kotaro Nomura, et al.
The Annals of Thoracic Surgery
|
October 31, 2025
Safety Profile of Neoadjuvant Chemoimmunotherapy With Nivolumab for Patients With Resectable Non-Small Cell Lung Cancer in the Real World (CReGYT-04 Neo-Venus)
Kotaro Nomura, Takuya Watanabe, Shinkichi Takamori, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 80) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 80 results.
Cancer Immunology, Immunotherapy : CII
|
April 15, 2023
Characteristic differences in the abundance of tumor-infiltrating lymphocytes and intratumoral developing T cells in thymoma, with special reference to PD-1 expression
Tatsuo Furuya, Shunta Ishihara, Hiroshi Ogi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
October 27, 2024
[Safety and Efficacy of Nivolumab plus Ipilimumab Therapy-Our Real World Experience]
Ryuichi Morita, Takeshi Ishikawa, Toshifumi Doi, et al.
Molecular Biology of the Cell
|
November 19, 2025
Hydrostatic pressure from basal side promotes cancer proliferation, enhances migration, and alters cell polarity: A model of the effects of interstitial fluid pressure in tumor microenvironment
Keisuke Onoi, Aosa Nakamura-Sasada, Shinsaku Tokuda, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 1, 2019
Comparing three different anti-PD-L1 antibodies for immunohistochemical evaluation of small cell lung cancer
Akihiro Yoshimura, Tadaaki Yamada, Aya Miyagawa-Hayashino, et al.
Cancers
|
October 14, 2022
Phosphoproteomic Analysis Identifies TYRO3 as a Mediator of Sunitinib Resistance in Metastatic Thymomas
Stefan Küffer, Jessica Grabowski, Satoru Okada, et al.
Translational Lung Cancer Research
|
July 17, 2025
Impact of mutant protein expression on clinical outcomes in patients with EGFR L858R-mutated non-small cell lung cancer
Ryota Nakamura, Tadaaki Yamada, Kenji Morimoto, et al.
Annals of Surgical Oncology
|
February 26, 2026
Efficacy and Safety of Salvage Surgery After Immunotherapy in Non-small Cell Lung Cancer: A Multi-institutional Retrospective Study
Shinya Tane, Megumi Nishikubo, Takehiko Manabe, et al.
Cell Death & Disease
|
December 3, 2025
Proteasome inhibition as a potential therapeutic target in thymic cancer
Satoru Okada, Louisa Benter, Leon Schrell, et al.
Lung Cancer (Amsterdam, Netherlands)
|
March 1, 2026
Lack of impact of antibiotics and proton pump inhibitors on the efficacy of preoperative chemoimmunotherapy in locally advanced non-small cell lung cancer: A multicenter retrospective study
Michihito Toda, Kazuki Takada, Kotaro Nomura, et al.
The Annals of Thoracic Surgery
|
October 31, 2025
Safety Profile of Neoadjuvant Chemoimmunotherapy With Nivolumab for Patients With Resectable Non-Small Cell Lung Cancer in the Real World (CReGYT-04 Neo-Venus)
Kotaro Nomura, Takuya Watanabe, Shinkichi Takamori, et al.
Page
of 8